A kinase inhibitor, sorafenib, used in the treatment of renal cell carcinoma and hepatocellular carcinoma, is an example of an Hsp70 targeting anticancer drug which functions to reduce the expression of Grp78 in cancer cells [39]. The gene discussed is HSPA4; the disease is cancer.